Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future
- Posted on September 1, 2026
- Novo Nordisk A/S
- By The New York Times
- 0 Views
- 1 min read
In brief
Generating AI summary…
Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future
Novo Nordisk’s chief executive, Mike Doustdar, is a year into a corporate turnaround. He says investors are still underestimating the promise of the company’s drugs. continue reading...
